A National Institutes of Health official says the Biden administration’s proposed biomedical research agency, the Advanced Research Projects Agency for Health (ARPA-H), could work with industry and federal agencies, including FDA, to bring ARPA-H-funded projects to the broader public. That can happen through several mechanisms, including by incentivizing industry to develop medical products and working with the government to reduce regulatory hurdles, NIH Associate Deputy Director Tara Schwetz said during an ARPA-H listening session with stakeholders on Friday (July 13)...